Fumihiro Tanaka
- Pulmonary and Respiratory Medicine top 0.2%
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Surgery top 2%
- Co-authors
- Hiromi WadaHidetaka UramotoKazuhiro YanagiharaRyo MiyaharaKazue YonedaYosuke OtakeSeiki HasegawaYozo Kawano
- Topics
- Lung Cancer Diagnosis and Treatment (103 papers)Lung Cancer Treatments and Mutations (101 papers)Pleural and Pulmonary Diseases (52 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Fumihiro Tanaka
382 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Pulmonary and Respiratory Medicine 4.4k
- Oncology 3.8k
- Molecular Biology 2.3k
- Cancer Research 1.5k
- Surgery 1.3k
Countries citing papers authored by Fumihiro Tanaka
This map shows the geographic impact of Fumihiro Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiro Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiro Tanaka more than expected).
Fields of papers citing papers by Fumihiro Tanaka
This network shows the impact of papers produced by Fumihiro Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiro Tanaka. The network helps show where Fumihiro Tanaka may publish in the future.
Co-authorship network of co-authors of Fumihiro Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiro Tanaka. A scholar is included among the top collaborators of Fumihiro Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiro Tanaka. Fumihiro Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 107 | |
| 5 | 47 | |
| 6 | 1 | |
| 7 | The Safety Indicator of Radiotherapy for Advanced Hepatoma with Liver Cirrhosis | 2 |
| 8 | 1 | |
| 9 | Comparison of Therapeutic Effect of Miriplatin Suspension Versus Miriplatin Emulsion in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: A Prospective Evaluation | 0 |
| 10 | 0 | |
| 11 | Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI. | 23 |
| 12 | 11 | |
| 13 | The prognostic significance of HER2 overexpression in non-small cell lung cancer. | 32 |
| 14 | 1 | |
| 15 | 47 | |
| 16 | 57 | |
| 17 | Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. | 160 |
| 18 | 1 | |
| 19 | 15 | |
| 20 | [Four cases of spontaneous pneumothorax with no reexpansion of collapsed lung despite chest tube drainage]. | 12 |
About Fumihiro Tanaka
Fumihiro Tanaka is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 404 papers that have together received 8.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (103 papers), Lung Cancer Treatments and Mutations (101 papers) and Pleural and Pulmonary Diseases (52 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (4.4k citations) and Cancer Research (1.5k citations). Fumihiro Tanaka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiromi Wada, Hidetaka Uramoto, Kazuhiro Yanagihara, Ryo Miyahara, Kazue Yoneda, Yosuke Otake, Seiki Hasegawa, Yozo Kawano, Kazumasa Takenaka and Mio Li. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.